Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Ascendis Pharma A/S
ASND | US
229.27
USD4.27
1.90%
ASND | US
Loading StockChartView...
About Ascendis Pharma A/S
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
229.27
Open
224.21
High
229.59
Low
222.02
Ascendis Pharma A/S a biopharmaceutical company focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD adult GHD and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/" for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup Denmark."
View LessASND | US
Risk
41.4
Sharpe
1.10
Luna's Score
49/100
Recommendation
Hold
Luna says (ASND | US)
What's Working
Strength based on increasing price with high volume
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
What's not Working
Price Below SMA10D
High Short-term Volatility
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
37.2%1 month
41.4%3 months
37.1%6 months
38.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
14.55
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-20.75
Ent. to rev.
23.25
PEG
-
Other Fundamentals
EBITDA
-347.19M
MarketCap
13.70B
MarketCap(USD)
13.70B
Div. yield
-
Op. margin
-370.18
Erngs. growth
-
Rev. growth
-24.00
Ret. on equity
-818.43
Short ratio
2.99
Short perc.
7.59
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
28.72
Range1M
35.72
Range3M
39.74
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.00
Price X volume
142.03M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -20.75 | 0.53 | Cheaper |
| Ent. to Revenue | 23.25 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 14.55 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 37.09 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 13.70B | 3.66B | Market Leader |
